These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1974145)

  • 1. Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid.
    Douglas CM; Collier RJ
    Biochemistry; 1990 May; 29(21):5043-9. PubMed ID: 1974145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity.
    Douglas CM; Collier RJ
    J Bacteriol; 1987 Nov; 169(11):4967-71. PubMed ID: 2889718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.
    Carroll SF; Collier RJ
    J Biol Chem; 1987 Jun; 262(18):8707-11. PubMed ID: 2885323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553.
    Killeen KP; Collier RJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):162-6. PubMed ID: 1347236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity.
    Tweten RK; Barbieri JT; Collier RJ
    J Biol Chem; 1985 Sep; 260(19):10392-4. PubMed ID: 2863266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine.
    Wilson BA; Reich KA; Weinstein BR; Collier RJ
    Biochemistry; 1990 Sep; 29(37):8643-51. PubMed ID: 1980208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eliminating a disulfide bridge within domain II of Pseudomonas aeruginosa exotoxin A.
    Madshus IH; Collier RJ
    Infect Immun; 1989 Jul; 57(7):1873-8. PubMed ID: 2499539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of exotoxin A proteins with mutations at histidine 426.
    Wick MJ; Cook JM; Iglewski BH
    Infect Immun; 1992 Mar; 60(3):1128-39. PubMed ID: 1541528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dipeptide insertion in domain I of exotoxin A that impairs receptor binding.
    Chaudry GJ; Wilson RB; Draper RK; Clowes RC
    J Biol Chem; 1989 Sep; 264(25):15151-6. PubMed ID: 2570071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A periplasmic intermediate in the extracellular secretion pathway of Pseudomonas aeruginosa exotoxin A.
    Lu HM; Mizushima S; Lory S
    J Bacteriol; 1993 Nov; 175(22):7463-7. PubMed ID: 7901198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.
    Lukac M; Pier GB; Collier RJ
    Infect Immun; 1988 Dec; 56(12):3095-8. PubMed ID: 2460407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical analysis of CRM 66. A nonfunctional Pseudomonas aeruginosa exotoxin A.
    Galloway DR; Hedstrom RC; McGowan JL; Kessler SP; Wozniak DJ
    J Biol Chem; 1989 Sep; 264(25):14869-73. PubMed ID: 2504713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of enzymic activity and cytotoxicity of mutant, E553C, Pseudomonas aeruginosa exotoxin A by reaction with iodoacetic acid.
    Lukac M; Collier RJ
    J Biol Chem; 1988 May; 263(13):6146-9. PubMed ID: 3129420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exotoxin A of Pseudomonas aeruginosa: active, cloned toxin is secreted into the periplasmic space of Escherichia coli.
    Douglas CM; Guidi-Rontani C; Collier RJ
    J Bacteriol; 1987 Nov; 169(11):4962-6. PubMed ID: 3117768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.